Zobrazeno 1 - 10
of 7 074
pro vyhledávání: '"A D, Ross"'
Autor:
Kheireddin Mufti, Miguel Cordova, Erika N. Scott, Jessica N. Trueman, Jessica M. Lovnicki, Catrina M. Loucks, Shahrad R. Rassekh, Colin J. D. Ross, Bruce C. Carleton, On behalf of the Canadian Pharmacogenomics Network for Drug Safety Consortium
Publikováno v:
npj Genomic Medicine, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract Vincristine-induced peripheral neuropathy is a common and highly debilitating toxicity from vincristine treatment that affects quality of life and often requires dose reduction, potentially affecting survival. Although previous studies demon
Externí odkaz:
https://doaj.org/article/d1cc86bec2d7493b863a8311ebbe1998
Autor:
Andrew D. Ross, Diptarka Hait, Valeriu Scutelnic, Daniel M. Neumark, Martin Head-Gordon, Stephen R. Leone
Publikováno v:
Communications Physics, Vol 7, Iss 1, Pp 1-10 (2024)
Abstract X-ray Transient Absorption Spectroscopy (XTAS) is a powerful probe for ultrafast molecular dynamics. The evolution of XTAS signal is controlled by the shapes of potential energy surfaces of the associated core-excited states, which are diffi
Externí odkaz:
https://doaj.org/article/ed425a5921744fd98e11e2ef38510156
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract For the recently legalized US hemp industry (Cannabis sativa), cross-pollination between neighboring fields has become a significant challenge, leading to contaminated seeds, reduced oil yields, and in some cases, mandated crop destruction.
Externí odkaz:
https://doaj.org/article/4609d57b61b34cc585c98c2d56c5deed
Autor:
Aung Naing, Danny Khalil, Matthew Thomas, Tom Lillie, Oliver Rosen, Lee Rosen, D Ross Camidge, Rui-Ru Ji, Andrea Stacey
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 12, Iss 10 (2024)
Background Tumor-selective oncolytic viral vectors are promising anticancer therapeutics; however, challenges with dosing and potency in advanced/metastatic cancers have limited efficacy and usage. NG-350A is a next-generation blood-stable adenoviral
Externí odkaz:
https://doaj.org/article/271f6fd5885648ffbf19df0742770c6d
Autor:
Wanderson de Souza, S. Gemini-Piperni, Carolina Ruivo, Nuno Bastos, Sofia Almeida, Daniel Lopes, Patricia Cardoso, Maria Jose Oliveira, D. Rick Sumner, Ryan D. Ross, Joshua J. Jacobs, Jose Mauro Granjeiro, Maria Helena Fernandes, Luis A. Rocha, Sonia Melo, Ana R. Ribeiro
Publikováno v:
Materials Today Bio, Vol 28, Iss , Pp 101189- (2024)
The inflammatory response to wear particles derived from hip prothesis is considered a hallmark of periprosthetic osteolysis, which can ultimately lead to the need for revision surgery. Exosomes (Exos) have been associated with various bone pathologi
Externí odkaz:
https://doaj.org/article/c575f46075f843ee99f6867f32f4ed0a
Autor:
Carolyn E. Dunford, J. Philip B. Faure, Michael D. Ross, J. Andrew Spalton, Marine Drouilly, Kai J.P. Pryce-Fitchen, Ross De Bruin, Alexander E. Botha, Abdullah Alshehri, Nikki Le Roex, Guy Balme, Ahmed Almalki, Emma Gallacher, Mesfer Alhlafi, Saleh Alaamri, David R. Mills, Gareth Mann
Publikováno v:
Oryx, Vol 58, Pp 351-362 (2024)
The Arabian leopard Panthera pardus nimr is categorized as Critically Endangered, with < 200 individuals estimated to remain in the wild. Historically the species ranged over an extensive area of western Saudi Arabia but, with no confirmed sightings
Externí odkaz:
https://doaj.org/article/6655206c13754193a72d1dddf3fac053
Autor:
Margaret Stalker, MD, Connor B. Grady, MPH, Alex Watts, MS, Wei-Ting Hwang, PhD, Krishna Chandrasekhara, MS, Fangdi Sun, MD, Geoffrey Liu, MD, Devalben Patel, MD, Jorge Nieva, MD, Amanda Herrmann, MD, Kristen Marrone, MD, Vincent K. Lam, MD, Vamsidhar Velcheti, MD, Stephen V. Liu, MD, Gabriela Liliana Bravo Montenegro, MD, William Tompkins, MD, Tejas Patil, MD, Jared Weiss, MD, Kelsey Leigh Miller, MD, William Schwartzman, MD, Jonathan E. Dowell, MD, Khvaramze Shaverdashvili, MD, PhD, Liza Villaruz, MD, Amanda Cass, PharmD, Wade Iams, MD, Dara Aisner, MD, PhD, Charu Aggarwal, MD, MD, D. Ross Camidge, MD, PhD, Lova Sun, MD, Melina E. Marmarelis, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 6, Iss 1, Pp 100765- (2025)
Introduction: Osimertinib is now a standard first-line (1L) therapy for EGFR-mutated (EGFRm) advanced NSCLC. We aimed to characterize patterns of therapy and longitudinal risk of brain and liver metastasis in a cohort of EGFRm NSCLC. Methods: Patient
Externí odkaz:
https://doaj.org/article/6bef8139f60a47f296c740f696efb851
Autor:
Rolando Quetzalcoatl Torres-García, Michelle R. Gaither, D. Ross Robertson, Eloisa Torres-Hernández, Jennifer E. Caselle, Jean-Dominique Durand, Arturo Angulo, Eduardo Espinoza-Herrera, Francisco J. García-De León, Jonathan Valdiviezo-Rivera, Omar Domínguez-Domínguez
Publikováno v:
PeerJ, Vol 12, p e18058 (2024)
The Tropical Indo-Pacific (TIP) includes about two thirds of the world’s tropical oceans and harbors an enormous number of marine species. The distributions of those species within the region is affected by habitat discontinuities and oceanographic
Externí odkaz:
https://doaj.org/article/e3dc5fbf1cc74848b8981c0da0760dcd
Autor:
William Tompkins, MD, Connor B. Grady, MPH, Wei-Ting Hwang, PhD, Krishna Chandrasekhara, Caroline McCoach, MD, Fangdi Sun, MD, Geoffrey Liu, MD, Devalben Patel, MD, Jorge Nieva, MD, Amanda Herrmann, MD, Kristen Marrone, MD, Vincent K. Lam, MD, Vamsi Velcheti, MD, Stephen V. Liu, MD, Gabriela Liliana Bravo Montenegro, MD, Tejas Patil, MD, Jared Weiss, MD, Kelsey Leigh Miller, MD, William Schwartzman, MD, Jonathan E. Dowell, MD, Khvaramze Shaverdashvili, MD, Liza Villaruz, MD, Amanda Cass, PharmD, Wade Iams, MD, Dara Aisner, MD, PhD, Charu Aggarwal, MD, D. Ross Camidge, MD, PhD, Melina E. Marmarelis, MD, Lova Sun, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 8, Pp 100669- (2024)
Introduction: Characteristics of long-term survivors in EGFR-mutant (EGFRm) NSCLC are not fully understood. This retrospective analysis evaluated a multi-institution cohort of patients with EGFRm NSCLC treated in the pre-osimertinib era and sought to
Externí odkaz:
https://doaj.org/article/0d3a7a8c7ded4bf788294fa0471d93f0
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100673- (2024)
Repotrectinib, licensed in November 2023, is a novel ROS1 tyrosine kinase inhibitor (TKI) with activity against G2032R, the most common resistance mutation to prior generations of ROS1 TKIs. Here, we report a case of a patient who was heavily pretrea
Externí odkaz:
https://doaj.org/article/7431ea6377e4481c94bd50a8012202bb